CERS - Cerus Inc Growth-Adjusted Payback Ratio

Corporate company logo of cerus.com (CERS)

The PEG ratio illustrates the valuation dynamics of Cerus Corporation (CERS), where the value 0.00 describes the current level. Organic growth is driven by long-term government contracts and equipment integration. Blood safety is guaranteed through global alliances with medical centers for pathogen inactivation. Supply stability is maintained via redundant production lines at certified sites in Europe and the US.

Cerus Inc (CERS): Price/Earnings to Growth Ratio from 07/04/2022 to 11/15/2026

Cerus Corporation (CERS) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart Cerus Corporation|CERS - Consensus Target
- market capitalization statistics:
Market Value Cerus Inc|CERS - Enterprise Value
- book capitalization indicators:
Net Assets per Share Cerus|CERS - Company Book Value|Capitalization to Book Value Ratio cerus.com|CERS - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Cerus Corporation|CERS - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Cerus Corp.|CERS - Company Debts|Debt to Net Assets Ratio Cerus Corporation|CERS - Company Long-Term Liabilities|Company Short-Term Debts Cerus|Quick Liquidity Indicator cerus.com
- net income and valuation ratios data:
CERS - Net Profit|Expected Net Profit Cerus Corporation|CERS - Price to Earnings Ratio|Price to Future Earnings Ratio Cerus|CERS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Cerus|CERS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Cerus|CERS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months cerus.com|CERS - Earnings growth in current year|Expected net earnings per share growth next year Cerus Corporation
- total revenue and sales volume data:
CERS - Company Revenue|Company Future Revenue Cerus Corporation|CERS - Market Cap to Revenue|Forward P/S Multiple Cerus
Fundamental company analysis:Cerus Corporation, CERS
Core merchandise of Cerus Inc

Professional investors utilize the P/E to earnings growth ratio to identify undervalued assets with high growth potential. This PEG momentum indicator determines the fair value of an asset by comparing the market price with revenue dynamics; in the case of Cerus Corporation (CERS), stable cash flow and predictable capex make this indicator an accurate navigator for identifying phases of business undervaluation.

Who Cerus Corporation competes with

Price/Earnings to Growth Ratio ISRG (Intuitive Surgical)|PEG Multiple DHR (danaher.com)|Growth-Adjusted Market Cap to Net Income bd.com (BDX)|STE - Price/Earnings to Growth Ratio|WST (West Pharma) - Growth-Adjusted P/E Ratio|Baxter Healthcare (BAX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio MASI|Price/Earnings to Growth Ratio stevanatogroup.com|TFX (teleflex.com) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple MMSI (Merit Medical Systems)|Company Value to Earnings Growth Ratio NVST|Price/Earnings to Growth Ratio ICU Medical Corp ICUI|Growth-Adjusted Payback Ratio XRAY|LMAT: Price/Earnings to Growth Multiple|ATRC - PEG Multiple|STAAR Surgical Co. (STAA) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple ChromaDex Corp.|ZIMV (zimvie.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate AngioDynamics Inc. ANGO|Price/Earnings to Growth Ratio Teknova (TKNO)|Monogram Orthopedics - Growth-Adjusted P/E Ratio|Sharps Technology - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio INFU (InfuSystem Holdings)|UTMD - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income KORU Medical KRMD|Nyxoah (NYXH) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Microbot Medical Inc.|Price/Earnings to Growth Ratio Pro-Dex|Price to Earnings Adjusted for Growth Rate Zentek Ltd ZTEK|Price/Earnings to Growth Multiple ELUT (Elutia Inc)|Price/Earnings to Growth Ratio MLSS (Milestone Scientific Corp)|PEG Multiple NXGL (NEXGEL Inc)|PEG Multiple Retractable Tech RVP|Harvard Bioscience Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Femasys Corp FEMY|MHUA: PEG Multiple|Price/Earnings to Growth Multiple Predictive Oncology|Price/Earnings to Growth Multiple CJMB|ATRI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple NURO (NeuroMetrix, Inc.)